U.S. Brand Name
Symtuza
Abbreviation(s)
DRV/COBI/FTC/TAF
First U.S. Approval
NRTI Based?
No
One Dose Daily?
Yes
Single Tablet Regimen
Yes
U.S. FDA Label
U.S. Manufacturer
Other Reference Links
Formulations
| Strength | Formulation | Image | Description | Boosted |
|---|---|---|---|---|
|
DRV 800 mg, COBI 150 mg, FTC 200 mg, TAF 10 mg
|
Tablet
|
|
Yellow to yellowish-brown, capsule-shaped, film-coated tablets debossed with "8121" on one side and "JG" on the other side.
|
Yes
|
Adult dosing
| Dosage | Formulation |
|---|---|
|
1 tablet daily
|
Film-Coated Tablets
|
Assistance Programs
